TLR Therapeutics
About TLR Therapeutics
The startup develops targeted therapeutics for myelodysplastic syndrome and acute myeloid leukemia, utilizing a platform that focuses on solid tumors, including gastric cancer. Their approach aims to enhance treatment outcomes for patients by evaluating the efficacy of Tomaralimab-based therapies.
What does TLR Therapeutics do?
The startup develops targeted therapeutics for myelodysplastic syndrome and acute myeloid leukemia, utilizing a platform that focuses on solid tumors, including gastric cancer. Their approach aims to enhance treatment outcomes for patients by evaluating the efficacy of Tomaralimab-based therapies.
Where is TLR Therapeutics located?
TLR Therapeutics is based in Wilmington, United States.
How much funding has TLR Therapeutics raised?
TLR Therapeutics has raised 200000.
- Location
- Wilmington, United States
- Funding
- 200000
- Employees
- 3 employees